QQQ   314.01 (+0.69%)
QQQ   314.01 (+0.69%)
QQQ   314.01 (+0.69%)
QQQ   314.01 (+0.69%)
Log in
NASDAQ:DOX

Amdocs Stock Forecast, Price & News

$70.02
-0.31 (-0.44 %)
(As of 01/15/2021 08:00 PM ET)
Add
Compare
Today's Range
$69.97
Now: $70.02
$70.80
50-Day Range
$65.75
MA: $68.69
$70.93
52-Week Range
$44.05
Now: $70.02
$77.29
Volume20,570 shs
Average Volume673,440 shs
Market Capitalization$9.18 billion
P/E Ratio18.92
Dividend Yield1.87%
Beta0.76
Amdocs Limited, through its subsidiaries, provides software and services to the communications, cable and satellite, entertainment, and media industry service providers worldwide. The company offers a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support and operations, such as end-to-end systems integration, managed, testing, cloud, digital business operations, and consulting services that addresses service providers business imperatives, including consumer experience and monetization, media and digital services, enterprise and connected society, open cloud networks, new domains and disruptions, and services and hybrid operations. It also provides revenue guard services designed to detect and resolve revenue leakage, fraud, and cyber fraud; and the BriteBill, a multi-channel bill presentment platform. In addition, the company offers advertising and media services for media publishers, TV networks, video streaming providers, advertising agencies, and service providers. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri.
Amdocs logo

MarketRank

Overall MarketRank

2.23 out of 5 stars

Computer And Technology Sector

25th out of 94 stocks

Custom Computer Programming Services Industry

1st out of 2 stocks

Analyst Opinion: 1.4Community Rank: 2.9Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Custom computer programming services
Sub-IndustryIT Consulting & Other Services
Current SymbolNASDAQ:DOX
CUSIPG0260210
Phone1 314 212 7000
Employees25,875

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.17 billion
Cash Flow$5.63 per share
Book Value$27.19 per share

Profitability

Net Income$497.84 million

Miscellaneous

Market Cap$9.18 billion
Next Earnings Date2/2/2021 (Confirmed)
OptionableOptionable
$70.02
-0.31 (-0.44 %)
(As of 01/15/2021 08:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DOX News and Ratings via Email

Sign-up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Amdocs (NASDAQ:DOX) Frequently Asked Questions

How has Amdocs' stock been impacted by Coronavirus?

Amdocs' stock was trading at $61.42 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, DOX stock has increased by 14.0% and is now trading at $70.02.
View which stocks have been most impacted by COVID-19
.

Is Amdocs a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Amdocs stock.
View analyst ratings for Amdocs
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Amdocs?

Wall Street analysts have given Amdocs a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Amdocs wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Amdocs' next earnings date?

Amdocs is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for Amdocs
.

How can I listen to Amdocs' earnings call?

Amdocs will be holding an earnings conference call on Tuesday, February 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Amdocs' earnings last quarter?

Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings data on Tuesday, November, 10th. The technology company reported $1.23 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.19 by $0.04. The technology company had revenue of $1.05 billion for the quarter, compared to analysts' expectations of $1.03 billion. Amdocs had a net margin of 11.94% and a return on equity of 15.57%. Amdocs's revenue was up 2.2% compared to the same quarter last year. During the same period last year, the company earned $1.08 earnings per share.
View Amdocs' earnings history
.

How often does Amdocs pay dividends? What is the dividend yield for Amdocs?

Amdocs announced a quarterly dividend on Tuesday, November 10th. Investors of record on Thursday, December 31st will be given a dividend of $0.327 per share on Friday, January 22nd. This represents a $1.31 annualized dividend and a yield of 1.87%. The ex-dividend date is Wednesday, December 30th.
View Amdocs' dividend history
.

Is Amdocs a good dividend stock?

Amdocs pays an annual dividend of $1.31 per share and currently has a dividend yield of 1.87%. Amdocs has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Amdocs is 31.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Amdocs will have a dividend payout ratio of 27.52% next year. This indicates that Amdocs will be able to sustain or increase its dividend.
View Amdocs' dividend history.

What guidance has Amdocs issued on next quarter's earnings?

Amdocs updated its first quarter earnings guidance on Tuesday, November, 10th. The company provided EPS guidance of $1.09-1.15 for the period, compared to the Thomson Reuters consensus estimate of $1.14. The company issued revenue guidance of $1.055-1.095 billion, compared to the consensus revenue estimate of $1.06 billion.

What price target have analysts set for DOX?

4 Wall Street analysts have issued twelve-month price objectives for Amdocs' stock. Their forecasts range from $74.00 to $76.00. On average, they anticipate Amdocs' share price to reach $75.00 in the next year. This suggests a possible upside of 7.1% from the stock's current price.
View analysts' price targets for Amdocs
or view Wall Street analyst' top-rated stocks.

Are investors shorting Amdocs?

Amdocs saw a decline in short interest during the month of December. As of December 31st, there was short interest totaling 2,170,000 shares, a decline of 15.9% from the December 15th total of 2,580,000 shares. Based on an average daily trading volume, of 665,900 shares, the short-interest ratio is presently 3.3 days. Approximately 1.7% of the company's shares are sold short.
View Amdocs' Short Interest
.

Who are some of Amdocs' key competitors?

What other stocks do shareholders of Amdocs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include The Home Depot (HD), Pfizer (PFE), AT&T (T), NVIDIA (NVDA), Exxon Mobil (XOM), AbbVie (ABBV), International Business Machines (IBM), Johnson & Johnson (JNJ), Advanced Micro Devices (AMD) and Comcast (CMCSA).

Who are Amdocs' key executives?

Amdocs' management team includes the following people:
  • Mr. Joshua Sheffer, Pres, CEO & Director (Age 61)
  • Ms. Tamar Rapaport-Dagim, CFO & COO (Age 50)
  • Mr. Matthew E. Smith, Sec. & Head of Investor Relations (Age 49)
  • Mr. Gary Miles, Chief Marketing Officer
  • Darcy Antonellis, Head of Amdocs Media
  • Mr. Oren Marmur, Head of NFV - Amdocs Open Network
  • Mr. Rajat Raheja, Division Pres of Amdocs Devel. Center India Pvt. Ltd (Age 52)
  • Anthony Goonetilleke, Group Pres of Media, Network & Technology

What is Amdocs' stock symbol?

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Who are Amdocs' major shareholders?

Amdocs' stock is owned by a number of retail and institutional investors. Top institutional investors include Crossmark Global Holdings Inc. (0.08%), State of Alaska Department of Revenue (0.07%), HGK Asset Management Inc. (0.05%), Bowling Portfolio Management LLC (0.02%), Donald L. Hagan LLC (0.01%) and Orrstown Financial Services Inc. (0.01%).

Which major investors are selling Amdocs stock?

DOX stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Crossmark Global Holdings Inc., Bowling Portfolio Management LLC, and Sowell Financial Services LLC.

Which major investors are buying Amdocs stock?

DOX stock was purchased by a variety of institutional investors in the last quarter, including Raymond James Trust N.A., HGK Asset Management Inc., Diversified Trust Co, Donald L. Hagan LLC, Orrstown Financial Services Inc., OneAscent Financial Services LLC, and Wedge Capital Management L L P NC.

How do I buy shares of Amdocs?

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Amdocs' stock price today?

One share of DOX stock can currently be purchased for approximately $70.02.

How big of a company is Amdocs?

Amdocs has a market capitalization of $9.18 billion and generates $4.17 billion in revenue each year. The technology company earns $497.84 million in net income (profit) each year or $4.19 on an earnings per share basis. Amdocs employs 25,875 workers across the globe.

What is Amdocs' official website?

The official website for Amdocs is www.amdocs.com.

How can I contact Amdocs?

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.